Kohima News Paper

CD BioSciences Announces to Provide Global Scientists with Early Phase Clinical Services

 Breaking News
  • No posts were found

CD BioSciences Announces to Provide Global Scientists with Early Phase Clinical Services

February 26
04:36 2021
CD BioSciences, a US based supplier of clinical development services, has announced to provide global scientists with early phase clinical services, aiming to accelerate their drug development projects.

New York, USA – February 25, 2021 – CD BioScicences, a supplier of one-stop clinical trial services, announces to provide early phase clinical services to researchers worldwide. The company claims to guide global scientists through the challenges of clinical trial development, especially helping them to shorten the time consumed in early phase clinical trials, mitigate costs, and lower potential risks.

Early phase clinical trials, i.e., phase I and phase II trials, are key steps to achieve proof of concept and a critical milestone in drug development. During early phase clinical trials, scientists hyper focus on proving the viability of concept and ensuring the safety of patients. In fact, they are vital phases to lay the groundwork for later phase clinical trials that are yet to come. However, to get the target compound, scientists need to conduct rigorously strategic design of early phase trials and meticulous protocol execution.

Empowered by the state-of-the-art laboratory facilities and a team of clinical development professionals, CD BioSciences is a good option for international scientists when choosing an early phase CRO. The company provides firsthand clinical trial services and delivers top-quality data that ensures the compliance with regulatory standards while also making the best use of the funds.

CD BioSciences provides a wide range of early phase CRO services that are fully dedicated to expediting early phase programs. The company is capable of the following services:

* Protocol design and early phase concept and program development
* Protocol writing
* Regulatory and pre-IND/IND meeting consultation services
* Multi-site feasibility support based upon established QA-approved site network
* Dedicated phase I / early development project management group
* Phase I focused data management
* Biostatistics and statistical design planning specific to early development studies
* Clinical PK/PD and pharmacometrics
* Clinical monitoring
* Pharmacovigilance
* Site management
* Medical writing
* Regulatory submissions
* Scientific consultation and etc.

“We provide end-to-end services for our clients.” Says Helen James, Senior Scientist of CD BioSciences, “We have completed various integrated clinical trials with biologics and small molecules and accumulated extensive experience in clinical pharmacology studies. We’re always here ready to help.”

CD BioSciences has gathered a team of experts experienced in oncology, immunology, neurology, and other popular therapeutic areas and dedicated to satisfying the clients’ needs in clinical trials. Except for early phase services, the company is also ready to serve in later phase clinical trials. In addition, the company provides biostatistics services in all clinical phases, including study design, PK / PD analysis and modeling, interim analysis, cluster analysis, and etc.

To learn more about CD BioSciences’ early phase clinical trial services as well as the company itself, visit https://www.cd-biosciences.com. The company’s accountable and responsive experts are easy to reach via [email protected]. Any service inquiry will be answered ASAP once the request is received.

About CD BioSciences

Located in the US, CD BioSciences has been a supplier of one-stop clinical development services for over a decade. With years of development, the company has covered its services in the entire clinical trial lifecycle, including bioanalytical lab testing, clinical pharmacology, first-in-human (FIH), proof of concept (PoC), early phase trials, phase IIa trials, phase IIb-III trials, phase IIIb-IV trials, clinical data management, data analysis and reporting. The company continuously supports both domestic and international scientists in clinical trials to expedite their drug development projects.

Media Contact
Company Name: CD BioSciences
Contact Person: Michelle Moser
Email: Send Email
Phone: 1-315-636-4280
Country: United States
Website: https://www.cd-biosciences.com